The threshold for diagnosing impaired fasting glucose: A position statement by the European Diabetes Epidemiology Group

N. G. Forouhi, B. Balkau, K. Borch-Johnsen, J. Dekker, C. Glumer, Q. Qiao, A. Spijkerman, R. Stolk, A. Tabac, N. J. Wareham

    Publikation: Bidrag til tidsskriftArtikelForskningpeer review

    Abstrakt

    The category of IFG was introduced in the late 1990s to denote a state of non-diabetic hyperglycaemia defined by a fasting plasma glucose (FPG) concentration between 6.1 and 6.9 mmol/l. In 2003 the American Diabetes Association recommended that this diagnostic threshold be lowered to 5.6 mmol/l. The justification for lowering the threshold has been questioned. This simple change in cut-off value creates a pandemic of IFG, with a two- to five-fold increase in the prevalence of IFG across the world. Such a change in threshold has far-reaching public health implications. The European Diabetes Epidemiology Group (EDEG) has reviewed the evidence for this lower cut-off point for the definition of IFG and concludes that the previous definition should not be altered. EDEG further recommends that the value of all categorical definitions of non-diabetic hyperglycaemia should be reconsidered.

    OriginalsprogEngelsk
    Sider (fra-til)822-827
    Antal sider6
    TidsskriftDiabetologia
    Vol/bind49
    Udgave nummer5
    DOI
    StatusUdgivet - 1 maj 2006

    Fingeraftryk Udforsk hvilke forskningsemner 'The threshold for diagnosing impaired fasting glucose: A position statement by the European Diabetes Epidemiology Group' indeholder.

    Citationsformater